1887

Abstract

Effects on growth and toxin A production of sub-MIC concentrations of six different antibiotics were investigated in three strains of : reference strain NCTC 11223, a fully sequenced strain (630) and a locally endemic isolate (strain 338a). The antibiotics chosen for investigation were the agents used to treat -associated disease (CDAD), i.e. vancomycin and metronidazole, and four antibiotics that are commonly involved in precipitating CDAD (amoxycillin, clindamycin, cefoxitin and ceftriaxone). Strains were cultured in sublethal concentrations of antibiotics (1/2, 1/4 and 1/8 MIC) over 104 h and growth and toxin A production were measured three times a day. Effects varied between strain and antibiotic. The most common effect on growth of the strains was to increase the initial lag period by approximately 4 h, compared with antibiotic-free controls; however, strain NCTC 11223, which has high-level clindamycin resistance (⩾ 512 μg ml), showed no lag whatsoever in comparison with the controls when grown in this antibiotic. The most common effect on production of toxin A was in the onset of toxin elaboration. Normally, toxins began to appear at low levels in the early stationary phase, before accumulating to high levels by the start of decline. In the presence of sub-MIC antibiotics, this onset appeared before that of the antibiotic-free controls. This effect was seen with metronidazole, amoxycillin and clindamycin, rarely with vancomycin and never with cefoxitin. These results suggest a very complex, strain-dependent relationship between the effects of growth and toxin production.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.05387-0
2003-12-01
2019-11-14
Loading full text...

Full text loading...

/deliver/fulltext/jmm/52/12/JM521201.html?itemId=/content/journal/jmm/10.1099/jmm.0.05387-0&mimeType=html&fmt=ahah

References

  1. Barc, M. C., Depitre, C., Corthier, G., Collignon, A., Su, W. J. & Bourlioux, P. ( 1992;). Effects of antibiotics and other drugs on toxin production in Clostridium difficile in vitro and in vivo. Antimicrob Agents Chemother 36, 1332–1335.[CrossRef]
    [Google Scholar]
  2. Brown, R., Collee, J. G. & Poxton, I. R. ( 1996;). In Mackie and McCartney Practical Medical Microbiology, 14th edn, pp. 507–511. Edited by J. G. Collee, A. G. Fraser, B. P. Marmion & A. Simmons. Edinburgh: Churchill Livingstone.
  3. Dupuy, B. & Sonenshein, A. L. ( 1998;). Regulated transcription of Clostridium difficile toxin genes. Mol Microbiol 27, 107–120.[CrossRef]
    [Google Scholar]
  4. Farrell, R. J. & LaMont, J. T. ( 2000;). Pathogenesis and clinical manifestations of Clostridium difficile diarrhea and colitis. Curr Top Microbiol Immunol 250, 109–125.
    [Google Scholar]
  5. Farrow, K. A., Lyras, D. & Rood, J. I. ( 2001;). Genomic analysis of the erythromycin resistance element Tn5398 from Clostridium difficile. Microbiology 147, 2717–2728.
    [Google Scholar]
  6. Hennequin, C., Collignon, A. & Karjalainen, T. ( 2001;). Analysis of expression of GroEL (Hsp60) of Clostridium difficile in response to stress. Microb Pathog 31, 255–260.[CrossRef]
    [Google Scholar]
  7. Honda, T., Hernadez, I., Katoh, T. & Miwatani, T. ( 1983;). Stimulation of enterotoxin production of Clostridium difficile by antibiotics. Lancet i, 655.
  8. Ikeda, D., Karasawa, T., Yamakawa, K., Tanaka, R., Namiki, M. & Nakamura, S. ( 1998;). Effect of isoleucine on toxin production by Clostridium difficile in a defined medium. Zentbl Bakteriol 287, 375–386.[CrossRef]
    [Google Scholar]
  9. Karlsson, S., Burman, L. G. & Åkerlund, T. ( 1999;). Suppression of toxin production in Clostridium difficile VPI 10463 by amino acids. Microbiology 145, 1683–1693.[CrossRef]
    [Google Scholar]
  10. Karlsson, S., Dupuy, B., Mukherjee, K., Norin, E., Burman, L. G. & Åkerlund, T. ( 2003;). Expression of Clostridium difficile toxins A and B and their sigma factor TcdD is controlled by temperature. Infect Immun 71, 1784–1793.[CrossRef]
    [Google Scholar]
  11. Levner, M., Wiener, F. P. & Rubin, B. A. ( 1977;). Induction of Escherichia coli and Vibrio cholerae enterotoxins by an inhibitor of protein synthesis. Infect Immun 15, 132–137.
    [Google Scholar]
  12. Lorian, V. ( 1971;). Effect of antibiotics on staphylococcal hemolysin production. Appl Microbiol 22, 106–109.
    [Google Scholar]
  13. Lorian, V. & Gemmell, C. ( 1994;). Effect of low antibiotic concentrations on ultrastructure, virulence and susceptibility to immunodefences. In Antibiotics and Laboratory Medicine, 3rd edn, pp. 493–555. Edited by V. Lorian. Baltimore: Williams & Wilkins.
  14. Mani, N. & Dupuy, B. ( 2001;). Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor. Proc Natl Acad Sci U S A 98, 5844–5849.[CrossRef]
    [Google Scholar]
  15. McCoubrey, J., Starr, J., Martin, H. & Poxton, I. R. ( 2003;). Clostridium difficile in a geriatric unit: a prospective epidemiological study employing a novel S-layer typing method. J Med Microbiol 52, 573–578.[CrossRef]
    [Google Scholar]
  16. Mylonakis, E., Ryan, E. T. & Calderwood, S. B. ( 2001;). Clostridium difficile-associated diarrhea: a review. Arch Intern Med 161, 525–533.[CrossRef]
    [Google Scholar]
  17. National Committee for Clinical Laboratory Standards ( 1997;). Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria, 4th edn. Approved standard, NCCLS publication no. M11-A4. Villanova, PA: NCCLS.
  18. Onderdonk, A. B., Lowe, B. R. & Bartlett, J. G. ( 1979;). Effect of environmental stress on Clostridium difficile toxin levels during continuous cultivation. Appl Environ Microbiol 38, 637–641.
    [Google Scholar]
  19. Spigaglia, P. & Mastrantonio, P. ( 2002;). Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol 40, 3470–3475.[CrossRef]
    [Google Scholar]
  20. Yamakawa, K., Karasawa, T., Ikoma, S. & Nakamura, S. ( 1996;). Enhancement of Clostridium difficile toxin production in biotin-limited conditions. J Med Microbiol 44, 111–114.[CrossRef]
    [Google Scholar]
  21. Yoh, M., Yamamoto, K., Honda, T., Takeda, Y. & Miwatani, T. ( 1983;). Effects of lincomycin and tetracycline on production and properties of enterotoxins of enterotoxigenic Escherichia coli. Infect Immun 42, 778–782.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.05387-0
Loading
/content/journal/jmm/10.1099/jmm.0.05387-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error